Clinical features of Wilson's disease: An analysis of 83 cases

Lei JI; Ying ZHANG; Li KONG; Suxian ZHAO; Po CUI; Qingshan ZHANG; Lingbo KONG; Weiguang REN

doi:10.3969/j.issn.1001-5256.2022.08.023

Volume 38 Issue 8

Aug. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(8): 1843-1846

PDF( 1880 KB)

Clinical features of Wilson's disease: An analysis of 83 cases

DOI: 10.3969/j.issn.1001-5256.2022.08.023

Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China

More Information

Corresponding author: KONG Li, kongliyouxiang@sina.com(ORCID: 0000-0002-8179-8100)
Received Date: 2022-01-12
Accepted Date: 2022-02-28
Published Date: 2022-08-20

Abstract

Abstract

Objective To summarize the clinical features of patients with Wilson's disease (WD). Methods A retrospective analysis was performed for the clinical data of 83 patients with WD who were admitted to The Third Hospital of Hebei Medical University from April 2013 to August 2021, including clinical manifestations, Imaging examinations, laboratory examinations, liver histopathological examinations, and ATP7B gene testing results. The patients were divided into groups based on different clinical types. A one-way analysis of variance was used for comparison between groups. Results The youngest age was 3 years for the 83 patients with WD, among whom 39 (46.99%) had an age of ≤18 years, with a mean age of 21.16±14.87 years for all 83 patients. Of all patients, 63.86% had liver-type WD, 31 patients (37.35%) had developed liver cirrhosis at the time of consultation, and 5 patients (6.2%) attended the hospital due to acute or acute-on-chronic liver failure. Of all patients, 62(74.69%) were positive for corneal K-F ring, and the positive rate of K-F ring was 66.04% in the patients with liver-type WD. Among the 83 patients, 79(95.18%) had a reduction in blood ceruloplasmin, and 73(87.95%) had an increase in 24-hour urine copper. The liver histopathological results of 25 patients showed varying degrees of inflammation, fibrosis, steatosis, and copper particle deposition in liver tissue. The ATP7B gene testing results of 25 patients showed that c.2333G > T/p.R778L of exon 8 was the most common mutation site. Conclusion Most patients with WD have the manifestation of liver diseases, and the examinations of corneal K-F ring, serum ceruloplasmin, and 24-h urine copper have their own limitations. Liver pathology and ATP7B gene testing can be performed when it is unable to make a confirmed diagnosis.
- Hepatolenticular Degeneration,
- Disease Attributes,
- Diagnosis, Differential

FullText(HTML)

References(24)

References

[1]	CHENG N, WANG K, HU W, et al. Wilson disease in the South Chinese Han population[J]. Can J Neurol Sci, 2014, 41(3): 363-367. DOI: 10.1017/s0317167100017315.
[2]	SCHEIBER IF, BRǓHA R, DUŠEK P. Pathogenesis of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 43-55. DOI: 10.1016/B978-0-444-63625-6.00005-7.
[3]	Neurogenetics Group, Neurology Branch of Chinese Medical Association. Chinese guidelines for diagnosis and treatment of Wilson's disease 2021[J]. Chin J Neurol, 2021, 54(4): 310-319. DOI: 10.3760/cma.j.cn113694-20200826-00661. 中华医学会神经病学分会神经遗传学组. 中国肝豆状核变性诊治指南2021[J]. 中华神经科杂志, 2021, 54(4): 310-319. DOI: 10.3760/cma.j.cn113694-20200826-00661.
[4]	YANG X. Update on diagnosis and treatment of Wilson disease in China[J]. J Clin Hepatol, 2013, 29(12): 905-908. DOI: 10.3969/j.issn.1001-5256.2013.12.008. 杨旭. 更新观念, 提高我国肝豆状核变性诊治的临床水平[J]. 临床肝胆病杂志, 2013, 29(12): 905-908. DOI: 10.3969/j.issn.1001-5256.2013.12.008.
[5]	ABUDUXIKUER K, LI LT, QIU YL, et al. Wilson disease with hepatic presentation in an eight-month-old boy[J]. World J Gastroenterol, 2015, 21(29): 8981-8984. DOI: 10.3748/wjg.v21.i29.8981.
[6]	FIGUS A, ANGIUS A, LOUDIANOS G, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations[J]. Am J Hum Genet, 1995, 57(6): 1318-1324.
[7]	WIJAYASIRI P, HAYRE J, NICHOLSON ES, et al. Estimating the clinical prevalence of Wilson's disease in the UK[J]. JHEP Rep, 2021, 3(5): 100329. DOI: 10.1016/j.jhepr.2021.100329.
[8]	ZHOU SM, GUO LP, CAI WF, et al. Latest advances in the treatment of hepatolenticular degeneration[J]. J Clin Hepatol, 2020, 36(1): 218-221. DOI: 10.3969/j.issn.1001-5256.2020.01.052. 周思敏, 郭丽萍, 蔡王锋, 等. 肝豆状核变性的治疗现状[J]. 临床肝胆病杂志, 2020, 36(1): 218-221. DOI: 10.3969/j.issn.1001-5256.2020.01.052.
[9]	ZHANG DF, TENG JF. Direct sequencing of mutations in the copper-transporting P-type adenosine triphosphate (ATP7B) gene for diagnosis and pathogenesis of Wilson's disease[J]. Genet Mol Res, 2016, 15(3): 1-9. DOI: 10.4238/gmr.15038746.
[10]	ALAM ST, RAHMAN MM, ISLAM KA, et al. Neurologic manifestations, diagnosis and management of Wilson's disease in children—an update[J]. Mymensingh Med J, 2014, 23(1): 195-203.
[11]	IORIO R, D'AMBROSI M, MARCELLINI M, et al. Serum transaminases in children with Wilson's disease[J]. J Pediatr Gastroenterol Nutr, 2004, 39(4): 331-336. DOI: 10.1097/00005176-200410000-00006.
[12]	DONG QY, WU ZY. Advance in the pathogenesis and treatment of Wilson disease[J]. Transl Neurodegener, 2012, 1(1): 23. DOI: 10.1186/2047-9158-1-23.
[13]	SENIÓW J, MROZIAK B, CZŁONKOWSKA A, et al. Self-rated emotional functioning of patients with neurological or asymptomatic form of Wilson's disease[J]. Clin Neuropsychol, 2003, 17(3): 367-373. DOI: 10.1076/clin.17.3.367.18085.
[14]	HUANG P, DONG T, LI X, et al. Comparison the changes of related indexes of different traditional Chinese medicine syndrome types in patients with hepatolenticular degeneration[J]. 中国医药导报, 2022, 19(5): 163-166. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202205034.htm 黄鹏, 董婷, 李祥, 等. 肝豆状核变性患者不同中医证型相关指标的变化比较[J]. 中国医药导报, 2022, 19(5): 163-166. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202205034.htm
[15]	COFFEY AJ, DURKIE M, HAGUE S, et al. A genetic study of Wilson's disease in the United Kingdom[J]. Brain, 2013, 136(Pt 5): 1476-1487. DOI: 10.1093/brain/awt035.
[16]	KROLL CA, FERBER MJ, DAWSON BD, et al. Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease[J]. Mol Genet Metab, 2006, 89(1-2): 134-138. DOI: 10.1016/j.ymgme.2006.03.008.
[17]	HE N, WANG J, ZHAO LB, et al. One case of Wilson's disease in adults with right knee joint gull as initial symptom[J]. J Clin Hepatol, 2015, 31(2): 286-287. DOI: 10.3969/j.issn.1001-5256.2015.02.037. 贺娜, 王俊, 赵龙斌, 等. 右膝关节肿痛为首发症状的成人肝豆状核变性1例报告[J]. 临床肝胆病杂志, 2015, 31(2): 286-287. DOI: 10.3969/j.issn.1001-5256.2015.02.037.
[18]	YU H, XIE JJ, CHEN YC, et al. Clinical features and outcome in patients with osseomuscular type of Wilson's disease[J]. BMC Neurol, 2017, 17(1): 34. DOI: 10.1186/s12883-017-0818-1.
[19]	ZHAO T, FANG Z, TIAN J, et al. Imaging Kayser-Fleischer ring in Wilson disease using in vivo confocal microscopy[J]. Cornea, 2019, 38(3): 332-337. DOI: 10.1097/ICO.0000000000001844.
[20]	LUO JH, LIANG N. Clinical analysis of the relationship between corneal KF ring and hepatolenticular degeneration[J]. Chin J Integr Tradit West Med Liver Dis, 2011, 21(4): 241-242. DOI: 10.3969/j.issn.1005-0264.2011.04.020. 罗继红, 梁娜. 角膜K-F环与肝豆状核变性关系的临床分析[J]. 中西医结合肝病杂志, 2011, 21(4): 241-242. DOI: 10.3969/j.issn.1005-0264.2011.04.020.
[21]	European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease[J]. J Hepatol, 2012, 56(3): 671-685. DOI: 10.1016/j.jhep.2011.11.007.
[22]	SUN YP, HAN T. Analysis of head MRI manifestations of hepatolenticular degeneration and its correlation with clinical symptoms[J]. J Imag Res Med Appl, 2018, 2(2): 171-172. DOI: 10.3969/j.issn.2096-3807.2018.02.109. 孙雅苹, 韩彤. 肝豆状核变性头部MRI表现及其与临床症状相关性分析[J]. 影像研究与医学应用, 2018, 2(2): 171-172. DOI: 10.3969/j.issn.2096-3807.2018.02.109.
[23]	CHENG N, WANG H, WU W, et al. Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease[J]. Clin Genet, 2017, 92(1): 69-79. DOI: 10.1111/cge.12951.
[24]	ZHANG YG, NAN YM, ZHAO SX, et al. Clinicopathological features of Wilson disease: report of 29 cases[J]. Natl Med J China, 2013, 93(18): 1422-1425. DOI: 10.3760/cma.j.issn.0376-2491.2013.18.014. 张玉果, 南月敏, 赵素贤, 等. 29例肝豆状核变性临床病理特点分析[J]. 中华医学杂志, 2013, 93(18): 1422-1425. DOI: 10.3760/cma.j.issn.0376-2491.2013.18.014.

Relative Articles

[1]	Ying LIU, Benjian GAO, Xiaoli YANG, Cheng FANG, Song SU, Bo LI. Effect of hemihepatic vascular exclusion versus total hepatic vascular exclusion in hepatectomy for primary liver cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(1): 73-78. doi: 10.3969/j.issn.1001-5256.2021.01.015
[2]	Lei WANG, Kangwei LIU, Yuling DUAN, Xinyao LI, Cijun PENG. Current status of the application of robot-assisted laparoscopic hepatectomy[J]. Journal of Clinical Hepatology, 2021, 37(11): 2732-2736. doi: 10.3969/j.issn.1001-5256.2021.11.054
[3]	ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006
[4]	Chen Long, Li Yue. The risk factors and prediction systems for posthepatectomy complications[J]. Journal of Clinical Hepatology, 2019, 35(1): 217-221. doi: 10.3969/j.issn.1001-5256.2019.01.048
[5]	Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042
[6]	Tang DeSheng, Li FuJun. Current status of research on liver failure after liver cancer resection[J]. Journal of Clinical Hepatology, 2018, 34(5): 1123-1127. doi: 10.3969/j.issn.1001-5256.2018.05.043
[7]	Li Le, Chen JinMing, Liu ZhongHua, Li Qiang, Shi Ying. Application of enhanced recovery after surgery versus traditional rehabilitation program in hepatectomy: a Meta-analysis[J]. Journal of Clinical Hepatology, 2018, 34(2): 303-308. doi: 10.3969/j.issn.1001-5256.2018.02.017
[8]	Mai RongYun, Ye JiaZhou, Bai Tao, Ceng Jie, Chen Jie, Huang Shan, Wu FeiXiang, Li LeQun, Wu GuoBin. Advances in the prevention and treatment of posthepatectomy liver failure in patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(12): 2685-2692. doi: 10.3969/j.issn.1001-5256.2018.12.039
[9]	Liu Bin, Li WenGang, Chen FuZhen. Laparoscopic hepatectomy: the choice in the era of minimally invasive surgery[J]. Journal of Clinical Hepatology, 2017, 33(4): 643-646. doi: 10.3969/j.issn.1001-5256.2017.04.008
[10]	Chen Kai, Li XiangNong, Liu Kun, Nan YunGuang, Yang Jun. Clinical effect of hepatectomy versus extracapsular peeling in treatment of hepatic hemangioma[J]. Journal of Clinical Hepatology, 2017, 33(4): 699-704. doi: 10.3969/j.issn.1001-5256.2017.04.020
[11]	Wu Xiao, Xia Hao, Wu Jian, Zhang Ming. Clinical experience in treatment of complex intrahepatic bile duct stones by regular hepatectomy[J]. Journal of Clinical Hepatology, 2016, 32(9): 1756-1759. doi: 10.3969/j.issn.1001-5256.2016.09.025
[12]	Xu Feng, Tang Bin, Dai ChaoLiu, Wang Chao, Liu XiaoLin. Prevention of surgical site infection after liver cancer resection[J]. Journal of Clinical Hepatology, 2016, 32(11): 2199-2202. doi: 10.3969/j.issn.1001-5256.2016.11.045
[13]	Xu YanZhe, Ding YouMing, Wang Bin, Xu JunHui. Research progress in hemostatic techniques during partial hepatectomy[J]. Journal of Clinical Hepatology, 2015, 31(5): 813-815. doi: 10.3969/j.issn.1001-5256.2015.05.046
[14]	Zhang ShengJun, Liu MinLi, Chang Qi, Liu YongFeng. Efficacy comparison of precise and traditional liver resection in treatment of intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2015, 31(10): 1648-1651. doi: 10.3969/j.issn.1001-5256.2015.10.022
[15]	Shi YueFeng, Shao YingMei. Cause and prevention of pleural effusion after liver resection[J]. Journal of Clinical Hepatology, 2015, 31(9): 1551-1553. doi: 10.3969/j.issn.1001-5256.2015.09.048
[16]	Chen Kai, Qiu FuNan, Tian YiFeng, Lai ZhiDe, Zhou SongQiang, Yan MaoLin, Wang YaoDong. Application of hepatectomy without hepatic blood flow occlusion in treatment of primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(10): 1060-1063. doi: 10.3969/j.issn.1001-5256.2014.10.021
[17]	Xu JunHui, Ding YouMing, Wang Bin, Fang HanGang. Clinical value of laparoscopic hepatectomy in liver cancer patients with cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(6): 552-555. doi: 10.3969/j.issn.1001-5256.2014.06.019
[18]	Zhu Yu, Zhang Wei. Clinical application of absorbable clips in hepatectomy[J]. Journal of Clinical Hepatology, 2013, 29(12): 932-935. doi: 10.3969/j.issn.1001-5256.2013.12.015
[19]	Zhang MingChang, Wang YaZhen, Liu YaHui. Clinical outcomes of partial hepatectomy and management experience in pediatric hepatic cancer patients[J]. Journal of Clinical Hepatology, 2012, 28(12): 915-916+925.

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	翁叶婷，王冰. 机器人辅助完全腹腔镜下脾切断流术联合肝肿瘤切除术的护理配合. 机器人外科学杂志(中英文). 2024(02): 213-216 .
2.	刘菲，钟黄，魏尉，黄忠. MAFLD相关肝硬化门静脉血栓形成的临床特征及危险因素分析. 重庆医学. 2024(07): 1045-1049 .
3.	李大庆，鲁卫颖，陈临涛，万彦鑫，吴荣谦，张煜，杜肇清. 肝硬化患者脾切除术后发生肝癌的危险因素分析. 中华肝胆外科杂志. 2024(08): 561-565 .
4.	费振浩，段兴福，孙志为，王峻峰，陈业盛，唐建中. 经腹膜后入路单孔腹腔镜全脾切除术的临床应用效果. 肝胆胰外科杂志. 2024(11): 664-666+672 .
5.	杨雯敏，钟欣，彭蓝芬，胡锐，周小舟. 基于数据挖掘探讨中医治疗酒精性肝硬化的用药规律. 中西医结合肝病杂志. 2024(12): 1107-1112 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (934) PDF downloads(90)

Clinical features of Wilson's disease: An analysis of 83 cases

DOI: 10.3969/j.issn.1001-5256.2022.08.023